Febrile Neutropenia
Autor Jean A. Klasterskyen Limba Engleză Paperback – 24 feb 2014
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 348.43 lei 6-8 săpt. | |
Springer – 24 feb 2014 | 348.43 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 5 dec 1996 | 693.38 lei 6-8 săpt. |
Preț: 348.43 lei
Preț vechi: 366.78 lei
-5% Nou
Puncte Express: 523
Preț estimativ în valută:
66.69€ • 69.93$ • 55.11£
66.69€ • 69.93$ • 55.11£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781907673696
ISBN-10: 1907673695
Pagini: 96
Ilustrații: IX, 73 p. 7 illus. in color.
Dimensiuni: 127 x 201 x 20 mm
Greutate: 0.09 kg
Ediția:2014
Editura: Springer
Colecția Springer Healthcare
Locul publicării:Tarporley, United Kingdom
ISBN-10: 1907673695
Pagini: 96
Ilustrații: IX, 73 p. 7 illus. in color.
Dimensiuni: 127 x 201 x 20 mm
Greutate: 0.09 kg
Ediția:2014
Editura: Springer
Colecția Springer Healthcare
Locul publicării:Tarporley, United Kingdom
Public țintă
Professional/practitionerCuprins
Introduction Prevention of febrile neutropeniaPrediction of the risk of complications associated with febrile neutropeniaManagement of the low-risk patientsManagement of the non-low-risk patients with febrile neutropenia Management of persistent fever in patients with neutropenia despite empirical antibiotic administrationCosts associated with febrile neutropeniaAt the extremes of age: febrile neutropenia in children and elderly
Caracteristici
Reviews current treatment recommendations for febrile neutropenia based on guidelines and clinical trials
Easily accessible text and figures offer practical approaches for managing febrile neutropenia
Provides diagnostic and treatment algorithms for various patient populations affected by this disorder, also supported by guidelines and clinical trials
Includes supplementary material: sn.pub/extras
Easily accessible text and figures offer practical approaches for managing febrile neutropenia
Provides diagnostic and treatment algorithms for various patient populations affected by this disorder, also supported by guidelines and clinical trials
Includes supplementary material: sn.pub/extras
Descriere
Descriere de la o altă ediție sau format:
Febrile neutropenia is a common complication in cancer patients and has been studied for more than 30 years. This is a field of cancer in which much progress in supportive care has been made, significantly reducing the morbidity and mortality from infections. Tremendous numbers of patients have already benefited from specific antineoplastic therapy and an even greater number could benefit from the prevention of infection or from the allevation of symptoms as a result of effective prophylaxis or adequate therapeutic strategies. This book evaluates the achievements in the past and identifies the major existing problems. It gives an overview of therapeutic possibilities and presents new concepts and strategies for making further progress.
Febrile neutropenia is a common complication in cancer patients and has been studied for more than 30 years. This is a field of cancer in which much progress in supportive care has been made, significantly reducing the morbidity and mortality from infections. Tremendous numbers of patients have already benefited from specific antineoplastic therapy and an even greater number could benefit from the prevention of infection or from the allevation of symptoms as a result of effective prophylaxis or adequate therapeutic strategies. This book evaluates the achievements in the past and identifies the major existing problems. It gives an overview of therapeutic possibilities and presents new concepts and strategies for making further progress.